Return To The Previous Page
Buy a Package
Number Of Visible Items Remaining : 2 Item

Cumulative incidence and time to event for leukemic transformation of polycythemia vera

Cumulative incidence and time to event for leukemic transformation of polycythemia vera
Cumulative incidence and time to event for leukemic transformation of polycythemia vera among 1545 patients stratified by the first cytoreductive drugs they were exposed to. "Leukemogenic" drugs include chlorambucil, P32, and other alkylating agents; "non-leukemogenic," for the purposes of this figure, signifies the use of interferon alfa or anagrelide only; "nothing" refers to patients who were not exposed to any cytoreductive agent.
Reprinted by permission from: Macmillan Publisher Ltd: Leukemia. Tefferi A, Rumi E, Finazzi G, et al. Survival and prognosis among 1545 patients with contemporary polycythemia vera: an international study. Leukemia 2013; 27:1874. Copyright © 2013. www.nature.com/leu.
Graphic 90727 Version 2.0